Skip to content
Boca Raton City Online – Lifestyle
Author:
Capricor Therapeutics
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
July 27, 2026
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
June 26, 2026
Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference
June 26, 2026
Capricor Therapeutics to Present at Upcoming Investor Conferences
June 8, 2026
←
Previous Page
1
2